Validation of Anti-Adeno Associated Virus Serotype rh10 (AAVrh.10) Total and Neutralizing Antibody Immunogenicity Assays
Published 2023 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Validation of Anti-Adeno Associated Virus Serotype rh10 (AAVrh.10) Total and Neutralizing Antibody Immunogenicity Assays
Authors
Keywords
-
Journal
PHARMACEUTICAL RESEARCH
Volume -, Issue -, Pages -
Publisher
Springer Science and Business Media LLC
Online
2023-10-26
DOI
10.1007/s11095-023-03625-7
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Binding and neutralizing anti-AAV antibodies: Detection and implications for rAAV-mediated gene therapy
- (2023) Martin Schulz et al. MOLECULAR THERAPY
- Comparison of Pre-existing Anti-AAV8 Total Antibody Screening and Confirmatory Assays with a Cell-Based Neutralizing Assay in Normal Human Serum
- (2023) Yanshan Dai et al. AAPS Journal
- Various AAV Serotypes and Their Applications in Gene Therapy: An Overview
- (2023) Shaza S. Issa et al. Cells
- Testing preexisting antibodies prior to AAV gene transfer therapy: rationale, lessons and future considerations
- (2022) Jerry R. Mendell et al. Molecular Therapy-Methods & Clinical Development
- Clinical enrollment assay to detect preexisting neutralizing antibodies to AAV6 with demonstrated transgene expression in gene therapy trials
- (2022) Liching Cao et al. GENE THERAPY
- Immunogenicity assessment of AAV-based gene therapies: An IQ consortium industry white paper
- (2022) Tong-yuan Yang et al. Molecular Therapy-Methods & Clinical Development
- AAVrh10 vector corrects pathology in animal models of GM1 gangliosidosis and achieves widespread distribution in the CNS of nonhuman primates
- (2022) Michaël Hocquemiller et al. Molecular Therapy-Methods & Clinical Development
- Anti-AAV Antibodies in AAV Gene Therapy: Current Challenges and Possible Solutions
- (2021) Thomas Weber Frontiers in Immunology
- Vectored Immunotherapeutics for Infectious Diseases: Can rAAVs Be The Game Changers for Fighting Transmissible Pathogens?
- (2021) Wei Zhan et al. Frontiers in Immunology
- Adeno-associated virus serotype 9 antibodies in patients screened for treatment with onasemnogene abeparvovec
- (2021) John W. Day et al. Molecular Therapy-Methods & Clinical Development
- Recommendations for the Development of Cell-Based Anti-Viral Vector Neutralizing Antibody Assays
- (2020) Boris Gorovits et al. AAPS Journal
- AAV Vector Immunogenicity in Humans: A Long Journey to Successful Gene Transfer
- (2020) Helena Costa Verdera et al. MOLECULAR THERAPY
- Intra-CSF AAV9 and AAVrh10 Administration in Nonhuman Primates: Promising Routes and Vectors for Which Neurological Diseases?
- (2020) Karim Bey et al. Molecular Therapy-Methods & Clinical Development
- Quantitative Whole-Body Imaging of I-124-Labeled Adeno-Associated Viral Vector Biodistribution in Nonhuman Primates
- (2020) Douglas J. Ballon et al. HUMAN GENE THERAPY
- Current Clinical Applications of In Vivo Gene Therapy with AAVs
- (2020) Jerry R. Mendell et al. MOLECULAR THERAPY
- Adeno-associated virus vector as a platform for gene therapy delivery
- (2019) Dan Wang et al. NATURE REVIEWS DRUG DISCOVERY
- Therapeutic hFIX activity achieved after single AAV5-hFIX treatment in hemophilia B patients and NHPs with pre-existing anti-AAV5 NABs
- (2019) Anna Majowicz et al. Molecular Therapy-Methods & Clinical Development
- From Clinical Trials to Clinical Practice: Practical Considerations for Gene Replacement Therapy in SMA Type 1
- (2019) Samiah A. Al-Zaidy et al. PEDIATRIC NEUROLOGY
- The adeno-associated virus rh10 vector is an effective gene transfer system for chronic spinal cord injury
- (2019) Yutaka Hoshino et al. Scientific Reports
- The rapidly evolving state of gene therapy
- (2018) Alisha M. Gruntman et al. FASEB JOURNAL
- AAVrh.10-Mediated APOE2 Central Nervous System Gene Therapy for APOE4-Associated Alzheimer's Disease
- (2018) Jonathan B. Rosenberg et al. Human Gene Therapy Clinical Development
- Development of a Chemiluminescent ELISA Method for the Detection of Total Anti-Adeno Associated Virus Serotype 9 (AAV9) Antibodies
- (2018) Uma Kavita et al. Human Gene Therapy Methods
- Strategy to detect pre-existing immunity to AAV gene therapy
- (2017) L Falese et al. GENE THERAPY
- From the bench to clinical practice: understanding the challenges and uncertainties in immunogenicity testing for biopharmaceuticals
- (2016) G. R. Gunn et al. CLINICAL AND EXPERIMENTAL IMMUNOLOGY
- Adeno-Associated Virus (AAV) Mediated Dystrophin Gene Transfer Studies and Exon Skipping Strategies for Duchenne Muscular Dystrophy (DMD)
- (2015) Klaudia Kawecka et al. CURRENT GENE THERAPY
- Systemic AAVrh10 provides higher transgene expression than AAV9 in the brain and the spinal cord of neonatal mice
- (2015) Yannick Tanguy et al. Frontiers in Molecular Neuroscience
- AAVrh.10 immunogenicity in mice and humans. Relevance of antibody cross-reactivity in human gene therapy
- (2014) R Thwaite et al. GENE THERAPY
- Transduction efficiency of neurons and glial cells by AAV-1, -5, -9, -rh10 and -hu11 serotypes in rat spinal cord following contusion injury
- (2014) H A Petrosyan et al. GENE THERAPY
- Intracerebral Administration of Adeno-Associated Viral Vector Serotype rh.10 Carrying Human SGSH and SUMF1 cDNAs in Children with Mucopolysaccharidosis Type IIIA Disease: Results of a Phase I/II Trial
- (2014) Marc Tardieu et al. HUMAN GENE THERAPY
- Recommendations for the validation of immunoassays used for detection of host antibodies against biotechnology products
- (2008) Gopi Shankar et al. JOURNAL OF PHARMACEUTICAL AND BIOMEDICAL ANALYSIS
- Intravascular AAV9 preferentially targets neonatal neurons and adult astrocytes
- (2008) Kevin D Foust et al. NATURE BIOTECHNOLOGY
Add your recorded webinar
Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.
Upload NowBecome a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get Started